UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 59

Sortiert nach

p53 is a suppressor of inflammatory response in mice

The FASEB journal, 2005-06, Vol.19 (8), p.1030-1032

2005

Volltextzugriff (PDF)

MicroRNA-34 mediates AR-dependent p53-induced apoptosis in prostate cancer

Cancer biology & therapy, 2008-08, Vol.7 (8), p.1288-1296

2008

Volltextzugriff (PDF)

Mechanisms of prostate cancer cell survival after inhibition of AR expression

Journal of cellular biochemistry, 2009-02, Vol.106 (3), p.363-371

2009

Volltextzugriff (PDF)

TOFA (5-tetradecyl-oxy-2-furoic acid) reduces fatty acid synthesis, inhibits expression of AR, neuropilin-1 and Mcl-1 and kills prostate cancer cells independent of p53 status

Cancer biology & therapy, 2011-07, Vol.12 (1), p.80-85

2011

Volltextzugriff (PDF)

Calcium/calmodulin-dependent kinase II plays an important role in prostate cancer cell survival

Cancer biology & therapy, 2007-05, Vol.6 (5), p.732-742

2007

Volltextzugriff (PDF)

KN-93 inhibits androgen receptor activity and induces cell death irrespective of p53 and Akt status in prostate cancer

Cancer biology & therapy, 2010-02, Vol.9 (3), p.224-234

2010

Volltextzugriff (PDF)

Androgen regulates apoptosis induced by TNFR family ligands via multiple signaling pathways in LNCaP

Oncogene, 2005-10, Vol.24 (45), p.6773-6784

2005

Volltextzugriff (PDF)

Inhibition of p53 expression modifies the specificity of chromatin binding by the androgen receptor

Oncotarget, 2012-02, Vol.3 (2), p.183-194

2012

Volltextzugriff (PDF)

P53 and the proteasome regulate androgen receptor activity

Cancer biology & therapy, 2012-05, Vol.13 (7), p.553-558

2012

Volltextzugriff (PDF)

Functional genetic screening reveals the role of mitochondrial cytochrome b as a mediator of FAS-induced apoptosis

Proceedings of the National Academy of Sciences - PNAS, 2008-09, Vol.105 (38), p.14453-14458

2008

Volltextzugriff (PDF)

Mechanisms of Cell Death Induced by Histone Deacetylase Inhibitors in Androgen Receptor–Positive Prostate Cancer Cells

Molecular cancer research, 2006-02, Vol.4 (2), p.113-123

2006

Volltextzugriff (PDF)

Chemotherapeutic Agents Up-regulate the Cytomegalovirus Promoter : Implications for Bioluminescence Imaging of Tumor Response to Therapy

Cancer research (Chicago, Ill.), 2007-11, Vol.67 (21), p.10445-10454

2007

Volltextzugriff (PDF)

Trichostatin a (TSA) sensitizes the human prostatic cancer cell line DU145 to death receptor ligands treatment

Cancer biology & therapy, 2005-04, Vol.4 (4), p.388-396

2005

Volltextzugriff (PDF)

Caspase-2-Based Regulation of the Androgen Receptor and Cell Cycle in the Prostate Cancer Cell Line LNCaP

Genes & cancer, 2011-07, Vol.2 (7), p.745-752

2011

Volltextzugriff (PDF)

Unique resistance of breast carcinoma cell line T47D to TRAIL but not anti-Fas is linked to p43cFLIPL

Breast cancer research and treatment, 2008-02, Vol.107 (3), p.349-357

2008

Volltextzugriff (PDF)

Unique resistance of breast carcinoma cell line T47D to TRAIL but not anti-Fas is linked to p43cFLIP(L)

Breast cancer research and treatment, 2008-02, Vol.107 (3), p.349-357

2008

Volltextzugriff (PDF)

Prostate cancer-specific monoclonal antibody 5D4 significantly enhances the cytotoxicity of doxorubicin-loaded liposomes against target cells in vitro

Journal of drug targeting, 2008-01, Vol.16 (7-8), p.601-604

2008

Volltextzugriff (PDF)

Fas-mediated apoptosis in human prostatic carcinoma cell lines

Cancer research (Chicago, Ill.), 1997-05, Vol.57 (9), p.1758-1768

1997

Volltextzugriff (PDF)

Death receptor-induced cell death in prostate cancer

Journal of cellular biochemistry, 2004-01, Vol.91 (1), p.70-99

2004

Volltextzugriff (PDF)

Bcl-2 oncoprotein protects the human prostatic carcinoma cell line PC3 from TRAIL-mediated apoptosis

Oncogene, 2001-05, Vol.20 (22), p.2836-2843

2001

Volltextzugriff (PDF)

Cooperation of two mutant p53 alleles contributes to Fas resistance of prostate carcinoma cells

Cancer research (Chicago, Ill.), 2003-06, Vol.63 (11), p.2905-2912

2003

Volltextzugriff (PDF)

Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand–Mediated Activation of Mitochondria-Associated Nuclear Factor-κB in Prostatic Carcinoma Cell Lines

Molecular cancer research, 2004-10, Vol.2 (10), p.574-584

2004

Volltextzugriff (PDF)

Fas-mediated apoptosis in human prostatic carcinoma cell lines occurs via activation of caspase-8 and caspase-7

Cancer research (Chicago, Ill.), 1998-12, Vol.58 (24), p.5870-5875

1998

Volltextzugriff (PDF)

Cytochrome c is involved in Fas-mediated apoptosis of prostatic carcinoma cell lines

Cancer research (Chicago, Ill.), 2000-04, Vol.60 (8), p.2163-2168

2000

Volltextzugriff (PDF)

p53 is involved in tumor necrosis factor-α-induced apoptosis in the human prostatic carcinoma cell line LNCaP

Oncogene, 2000-04, Vol.19 (15), p.1959-1968

2000

Volltextzugriff (PDF)

1 – 25 von 59

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(57)
Mit Volltextzugriff
(53)

Publikationsform

Artikel
(59)

Sprache

Englisch
(59)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

p53 is a suppressor of inflammatory response in mice

MicroRNA-34 mediates AR-dependent p53-induced apoptosis in prostate cancer

Mechanisms of prostate cancer cell survival after inhibition of AR expression

TOFA (5-tetradecyl-oxy-2-furoic acid) reduces fatty acid synthesis, inhibits expression of AR, neuropilin-1 and Mcl-1 and kills prostate cancer cells independent of p53 status

Calcium/calmodulin-dependent kinase II plays an important role in prostate cancer cell survival

KN-93 inhibits androgen receptor activity and induces cell death irrespective of p53 and Akt status in prostate cancer

Androgen regulates apoptosis induced by TNFR family ligands via multiple signaling pathways in LNCaP

Inhibition of p53 expression modifies the specificity of chromatin binding by the androgen receptor

P53 and the proteasome regulate androgen receptor activity

Functional genetic screening reveals the role of mitochondrial cytochrome b as a mediator of FAS-induced apoptosis

Mechanisms of Cell Death Induced by Histone Deacetylase Inhibitors in Androgen Receptor–Positive Prostate Cancer Cells

Chemotherapeutic Agents Up-regulate the Cytomegalovirus Promoter : Implications for Bioluminescence Imaging of Tumor Response to Therapy

Trichostatin a (TSA) sensitizes the human prostatic cancer cell line DU145 to death receptor ligands treatment

Caspase-2-Based Regulation of the Androgen Receptor and Cell Cycle in the Prostate Cancer Cell Line LNCaP

Unique resistance of breast carcinoma cell line T47D to TRAIL but not anti-Fas is linked to p43cFLIPL

Unique resistance of breast carcinoma cell line T47D to TRAIL but not anti-Fas is linked to p43cFLIP(L)

Prostate cancer-specific monoclonal antibody 5D4 significantly enhances the cytotoxicity of doxorubicin-loaded liposomes against target cells in vitro

Fas-mediated apoptosis in human prostatic carcinoma cell lines

Death receptor-induced cell death in prostate cancer

Bcl-2 oncoprotein protects the human prostatic carcinoma cell line PC3 from TRAIL-mediated apoptosis

Cooperation of two mutant p53 alleles contributes to Fas resistance of prostate carcinoma cells

Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand–Mediated Activation of Mitochondria-Associated Nuclear Factor-κB in Prostatic Carcinoma Cell Lines

Fas-mediated apoptosis in human prostatic carcinoma cell lines occurs via activation of caspase-8 and caspase-7

Cytochrome c is involved in Fas-mediated apoptosis of prostatic carcinoma cell lines

p53 is involved in tumor necrosis factor-α-induced apoptosis in the human prostatic carcinoma cell line LNCaP

Suchergebnisse filtern